Stroke Clinical Trials
Active Studies: Acute Stroke
AtRial Cardiopathy and Antithrombotic Drugs in Prevention After cryptogenic stroke.
- AXIOMATIC-BMS
Condition studied: acute ischemic stroke, transient ischemic attack (TIA) - MASTERS-2- Athersys
Condition Studied: ischemic stroke - MOST Trial NIH/StrokeNET
Condition Studied: acute ischemic stroke - REDUCE PAS
Condition studied: ischemic stroke, patent foramen ovale (PFO) - SORT - Stroke and Artificial Intelligence (SORT) Screening Study
Condition studied: acute neurological symptoms, acute stroke, chronic stroke
- ARCADIA-NIH/StrokeNET
Condition studied: ischemic stroke - BUBL- Robotic TCD Ultrasound Bubble Study Compared to Transthoracic Echocardiography for Detection of Right to Left Shunt
Condition treated: embolic stroke of undetermined source (ESUS), transient ischemic attack (TIA), right-to-left atrial shunt, patent foramen ovale (PFO) - CREST-2 NIH/StrokeNET
Condition studied: carotid stenosis
- Music Listening in Stroke Recovery
Condition studied: ischemic stroke
- RELIEF
Condition studied: migraine, patent foramen ovale (PFO)
AXIOMATIC-BMS
A Global, Phase 2, Randomized, Double-Blind, Placebo-Controlled, Response-Adaptive Dose-Ranging Study of BMS-986177, an Oral Factor XIa Inhibitor, for the Prevention of New Ischemic Stroke or New Covert Brain Infarction in Patients Receiving Aspirin and Clopidogrel Following Acute Ischemic Stroke or Transient Ischemic Attack (TIA).- Study director (local PI): David Chiu, MD
- Condition studied: acute ischemic stroke, transient ischemic attack (TIA)
- ClinicalTrials.gov identifier: NCT03766581
- IRB #: Pro00022059
- IRB approval date: 08/22/2019
- To learn more email David McCane at dmccane@houstonmethodist.org or call 713.441.5801
MASTERS-2- Athersys
Multistem® Administration for Stroke Treatment and Enhanced Recovery Study. A Phase 3, randomized, double-blind, placebo-controlled, multicenter international study.- Study director (local PI): David Chiu, MD
- Condition Studied: ischemic stroke
- ClinicalTrials.gov identifier: NCT03545607
- IRB #: Pro00019190
- IRB approval date: 03/22/2018
- To learn more email David McCane at dmccane@houstonmethodist.org or call 713.441.5801
MOST Trial NIH/StrokeNET
Multi-arm Optimization of Stroke Thrombolysis (MOST): a blinded, randomized controlled adaptive, multi-arm, adjunctive-thrombolysis efficacy trial in ischemic stroke. Determine if argatroban or eptifibatide results in improved 90-day mRS as compared with placebo in acute ischemic stroke patients treated with IV rt-PA within three hours of symptom onset. Patients may also receive endovascular thrombectomy (ET) per usual care.- Study director (local PI): Vivek Misra, MD
- Condition Studied: acute ischemic stroke
- ClinicalTrials.gov identifier: NCT03735979
- IRB #: Pro00020938
- IRB approval date: 02/11/2019
- To learn more email David McCane at dmccane@houstonmethodist.org or call 713.441.5801
REDUCE PAS
Gore Cardioform Septal Occluder and Antiplatelet Medical Management for Reduction of Recurrent Stroke in Patients with Patient Foramen Ovale (PFO): the REDUCE Post Approval Study.- Study director (National PI): John J. Volpi, MD
- Study director (Local PI): Chun H. Lin, MD
- Condition studied: ischemic stroke, patent foramen ovale (PFO)
- ClinicalTrials.gov Identifier: NCT03821129
- IRB #: Pro00021260
- IRB approval date: 09/24/2019
- To learn more email Amber Criswell at acriswell@houstonmethodist.org or call 346.238.5214.
SORT - Stroke and Artificial Intelligence (SORT) Screening Study
This is a prospective screening study aimed to develop a rapid screening tool and artificial intelligence software to assist clinicians during triage for stroke. The study is actively enrolling both healthy volunteers and patients.- Study director (National PI): John J. Volpi, MD
- Condition studied: acute neurological symptoms, acute stroke, chronic stroke
- ClinicalTrials.gov Identifier: (None, not listed)
- IRB #: Pro00020577
- IRB approval date: 11/15/2018
- To learn more email Amber Criswell at acriswell@houstonmethodist.org or call 346.238.5214.
ARCADIA-NIH/StrokeNET
AtRial Cardiopathy and Antithrombotic Drugs in Prevention After cryptogenic stroke.
- Study director (local PI): Vivek Misra, MD
- Condition studied: ischemic stroke
- ClinicalTrials.gov Identifier: NCT03192215
- IRB #: Pro00019940
- IRB approval date: 07/06/2018
- Contact info: To learn more email David McCane at dmccane@houstonmethodist.org or call 713.441.5801
BUBL- Robotic TCD Ultrasound Bubble Study Compared to Transthoracic Echocardiography for Detection of Right to Left Shunt
Multi-center, prospective, single-arm, non-significant risk (NSR) device study in 150 patients with suspicion of embolic stroke of undetermined source.
- Study director (National PI): John J. Volpi, MD
- Condition treated: embolic stroke of undetermined source (ESUS), transient ischemic attack (TIA), right-to-left atrial shunt, patent foramen ovale (PFO)
- ClinicalTrials.gov Identifier: NCT04604015
- IRB #: Pro00026775
- IRB approval date: 11/10/2020
- To learn more email Amber Criswell at acriswell@houstonmethodist.org or call 346.238.5214.
CREST-2 NIH/StrokeNET
Carotid Revascularization for Primary Prevention of Stroke.- Study director (local PI): David Chiu, MD
- Condition studied: carotid stenosis
- ClinicalTrials.gov Identifier: NCT02089217
- IRB #: Pro00012292
- IRB approval date: 02/25/2015
- To learn more email David McCane at dmccane@houstonmethodist.org or call 713.441.5801
Music Listening in Stroke Recovery
Music listening or spoken word listening for patients with following a 90-day listening schedule for patients with recent stroke within 30days to 1 year.- Study director (National PI): John J. Volpi, MD
- Condition studied: ischemic stroke
- ClinicalTrials.gov Identifier: NCT03608904
- IRB #: Pro00015563
- IRB approval date: 12/22/2016
- To learn more email Jonathan Wiese at jrwiese@houstonmethodist.org or call 713.441.7161.
RELIEF
GORE® CARDIOFORM Septal Occluder Migraine Clinical Study: A Study to evaluate the safety and efficacy of transcatheter closure of patent foramen ovale for relief of migraine headaches. Multi-center, prospective, randomized, placebo- and sham-controlled study to evaluate the Gore Cardioform Septal Occluder for migraine headache relief.- Study direction (Local PI): Chun H. Lin, MD
- Condition studied: migraine, patent foramen ovale (PFO)
- ClinicalTrials.gov Identifier: NCT04100135
- IRB #: Pro00024894
- IRB approval date: 09/08/2020
- To learn more email Amber Criswell at acriswell@houstonmethodist.org or call 346.238.5214.